Interactions between age and apoE genotype on fasting and postprandial triglycerides levels

Atherosclerosis
Andrew L Carvalho-WellsAnne M Minihane

Abstract

The influences of genetic determinants on the magnitude of postprandial lipaemia are presently unclear. Here the impact of the common apolipoprotein (apo)E epsilon mutation on the postprandial triglyceride (TG) response is determined, along with an assessment of genotype penetrance according to age, body mass index and gender. Healthy adults (n=251) underwent a postprandial investigation, in which blood samples were taken at regular intervals after a test breakfast (0 min, 49 g fat) and lunch (330 min, 29 g fat) until 480 min after the test breakfast. There was a significant impact of apoE genotype on fasting total cholesterol (TC), (P=0.027), LDL-cholesterol (LDL-C), (P=0.008), and %LDL(3) (P=0.001), with higher and lower levels in the E4 and E2 carriers respectively relative to the E3/E3 genotype. Reflective of a higher fasting TG (P=0.001), a significantly higher area under the curve for the postprandial TG response (TG AUC) was evident in the E4 carriers relative to the E3/E3 group (P=0.038). In the group as a whole, a significant age×genotype interaction was observed for fasting TC (P=0.021). In the participants>50 years there was a significant impact of genotype on TC (P=0.005), LDL-C (P=0.001) and TAG AUC (P=0.028). It i...Continue Reading

References

Nov 11, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J R PatschW Patsch
Sep 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·T A MiettinenA Ollus
May 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·P H GrootL Havekes
Dec 1, 1987·The Journal of Clinical Investigation·M S WeintraubJ L Breslow
Sep 1, 1986·The Journal of Clinical Investigation·R E GreggH B Brewer
Jul 1, 1997·The Proceedings of the Nutrition Society·M A Austin
Jul 1, 1997·The Proceedings of the Nutrition Society·K N FraynB A Fielding
Oct 3, 1998·The Journal of Biological Chemistry·Y HuangR W Mahley
May 27, 1999·The Proceedings of the Nutrition Society·B A Griffin
Jan 5, 2000·The American Journal of Clinical Nutrition·H M Roche, M J Gibney
Aug 11, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·A M MinihaneC M Williams
Oct 29, 2000·The American Journal of Cardiology·P Cullen
Feb 13, 2001·The Journal of Clinical Investigation·S FazioR V Farese
Dec 4, 2003·Biochemical Society Transactions·K N Frayn
Oct 16, 2004·The Journal of Biological Chemistry·Joerg HeerenUlrike Beisiegel
Dec 24, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Joerg HeerenThomas Grewal
Apr 25, 2006·Journal of Lipid Research·Sarada D TetaliJohn C Rutledge
May 1, 2007·The Proceedings of the Nutrition Society·A M MinihaneG Rimbach
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Sandeep BansalPaul M Ridker
Aug 21, 2007·The British Journal of Nutrition·José Lopez-MirandaDenis Lairon
Sep 20, 2007·JAMA : the Journal of the American Medical Association·Anna M BennetJohn Danesh
Feb 12, 2008·Journal of Lipid Research·Estibaliz Olano-MartinAnne M Minihane
Jul 8, 2008·Atherosclerosis. Supplements·Pablo Perez-MartinezJose M Ordovas
Sep 10, 2008·The American Journal of Clinical Nutrition·Muriel J CaslakeAnne M Minihane
Feb 28, 2009·The Proceedings of the Nutrition Society·Gerald Rimbach, Anne M Minihane

❮ Previous
Next ❯

Citations

Jun 1, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Anne-Christin GraeserGerald Rimbach
May 2, 2013·The British Journal of Nutrition·R Chouinard-WatkinsM Plourde
May 9, 2012·The Proceedings of the Nutrition Society·Sarah EgertPatricia Huebbe
Jun 14, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Makoto AraiMinoru Okubo
Sep 15, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Caleb E Finch, Alexander M Kulminski
May 3, 2020·Neurology·Megan M BernathUNKNOWN Alzheimer's Disease Neuroimaging Initiative and Alzheimer's Disease Metabolomics Consortium
Sep 29, 2018·BMC Proceedings·Tony Huayang GaoXuexia Wang
Feb 27, 2020·PloS One·Paul T Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.